Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6452]

ESMO 2021: Artificial intelligence predicts the risk of recurrence for women with the most common breast cancer

ESMO 2021: Artificial intelligence predicts the risk of recurrence for women with the most common breast cancer

Right program could turn immune cells into cancer killers

Right program could turn immune cells into cancer killers

Saliva testing may allow early detection of human papillomavirus–driven head and neck cancers

Saliva testing may allow early detection of human papillomavirus–driven head and neck cancers

Unique aspects of pancreatic cancer proteins could lead to early detection, new treatments

Unique aspects of pancreatic cancer proteins could lead to early detection, new treatments

Scientists find a pair of proteins control supply lines that feed cancer cells

Scientists find a pair of proteins control supply lines that feed cancer cells

Innovative ovarian cancer research newly supported by R37 MERIT Award

Innovative ovarian cancer research newly supported by R37 MERIT Award

Artificial intelligence helps diagnose leukaemia

Artificial intelligence helps diagnose leukaemia

ESMO 2021: First-line CDK 4/6 inhibition shows overall survival benefit for metastatic breast cancer

ESMO 2021: First-line CDK 4/6 inhibition shows overall survival benefit for metastatic breast cancer

ESMO 2021: Adjuvant immunotherapy prolongs recurrence-free survival in resected stage II B/C melanoma

ESMO 2021: Adjuvant immunotherapy prolongs recurrence-free survival in resected stage II B/C melanoma

ESMO 2021: Immunotherapy prolongs survival in recurrent, persistent or metastatic cervical cancer

ESMO 2021: Immunotherapy prolongs survival in recurrent, persistent or metastatic cervical cancer

More from ecancer